Ablative Solutions Stock

ablativesolutions.comHealthcareFounded: 2011Funding to Date: $127.35MM

Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension.

Register for Details

For more details on financing and valuation for Ablative Solutions, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Kathryn Rumrill
President, Chief Executive Officer & Board Member
Nicole Haratani
Vice President of Global Clinical, Regulatory Affairs and Quality
Tim Fischell MD
Chief Medical Officer
Phillip Torrence JD
Board Member & Secretary

Board Members

Dale Grogan
Michigan Accelerator Fund 1
David Fischell Ph.D
Geoff Pardo
Gilde Healthcare Partners
Kathryn Rumrill
Ablative Solutions
Paul Buckman
Phillip Torrence JD

Other companies like Ablative Solutions in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$263MM

News

Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced that Kate Rumrill has been appointed a
Ablative Solutions, a company advancing innovative solutions for the treatment of hypertension, held the first close of its $77m Series D funding